Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2011; 17(18): 2353-2355
Published online May 14, 2011. doi: 10.3748/wjg.v17.i18.2353
Published online May 14, 2011. doi: 10.3748/wjg.v17.i18.2353
Table 1 Schedule of therapy and change in follow-up α-fetoprotein
| Time (yr-mo) | APF | TACE | H101 | Resection |
| (ng/mL) | (yes/no) | (yes/no) | (yes/no) | |
| 2006-06 | 1210.00 | Yes | ||
| 2006-07 | 143.20 | Yes | ||
| 2007-09 | 70.00 | Yes | ||
| 2007-11 | 21.67 | No | ||
| 2008-03 | 355.60 | Yes | ||
| 2008-04 | 491.16 | No | ||
| 2008-06 | 1390.00 | Yes | ||
| 2008-07 | 955.10 | No | ||
| 2008-08 | 1072.00 | Yes | ||
| 2008-09 | 595.40 | No | Yes | |
| 2008-10 | 10.99 | No | ||
| 2009-02 | 352.30 | Yes | ||
| 2009-03 | 724.00 | Yes | Yes | |
| 2009-05 | 338.40 | Yes | Yes | |
| 2009-07 | 4.56 | Yes | Yes | |
| 2010-12 | 2.28 | No |
- Citation: He Q, Liu Y, Zou Q, Guan YS. Transarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinoma. World J Gastroenterol 2011; 17(18): 2353-2355
- URL: https://www.wjgnet.com/1007-9327/full/v17/i18/2353.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i18.2353